+Compare
ABBV
Stock ticker:
NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
242.7B

ABBV Price Prediction, ABBVIE AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT May 26, 2023

ABBV in downward trend: 10-day moving average crossed below 50-day moving average on May 04, 2023

The 10-day moving average for ABBV crossed bearishly below the 50-day moving average on May 04, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 27, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on ABBV as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ABBV turned negative on April 27, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

ABBV moved below its 50-day moving average on April 27, 2023 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABBV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ABBV entered a downward trend on May 26, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABBV advanced for three days, in of 368 cases, the price rose further within the following month. The odds of a continued upward trend are .

ABBV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ABBV's P/B Ratio (18.282) is slightly higher than the industry average of (6.199). P/E Ratio (32.362) is within average values for comparable stocks, (30.267). ABBV's Projected Growth (PEG Ratio) (10.498) is slightly higher than the industry average of (3.530). ABBV has a moderately high Dividend Yield (0.042) as compared to the industry average of (0.027). P/S Ratio (4.308) is also within normal values, averaging (4.057).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ABBV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

A.I. Advisor
published Earnings

ABBV is expected to report earnings to rise 18.70% to $2.92 per share on July 28

ABBVIE ABBV Stock Earnings Reports
Q2'23
Est.
$2.92
Q1'23
Est.
$2.46
Q4'22
Beat
by $0.07
Q3'22
Beat
by $0.08
Q2'22
Beat
by $0.05
The last earnings report on April 27 showed earnings per share of $2.46, meeting the estimate of $2.46. With 7.33M shares outstanding, the current market capitalization sits at 242.70B.
A.I.Advisor
published Dividends

ABBV paid dividends on May 15, 2023

ABBVIE ABBV Stock Dividends
А dividend of $1.48 per share was paid with a record date of May 15, 2023, and an ex-dividend date of April 13, 2023. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 80.33B. The market cap for tickers in the group ranges from 72.83K to 404.19B. LLY holds the highest valuation in this group at 404.19B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -2%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 2%. SNPHF experienced the highest price growth at 7%, while SCLX experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was 125%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 28
P/E Growth Rating: 56
Price Growth Rating: 53
SMR Rating: 52
Profit Risk Rating: 59
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEVA1.150.05
+4.55%
Aeva Technologies
SBR72.572.58
+3.69%
Sabine Royalty Trust
ACAD24.780.33
+1.35%
ACADIA Pharmaceuticals
USB30.670.16
+0.52%
US Bancorp
JG0.31N/A
-0.19%
Aurora Mobile Limited

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
-0.76%
PFE - ABBV
54%
Loosely correlated
-0.61%
JNJ - ABBV
50%
Loosely correlated
-0.04%
MRK - ABBV
49%
Loosely correlated
-1.10%
AMGN - ABBV
49%
Loosely correlated
-0.24%
BMY - ABBV
44%
Loosely correlated
-1.15%
More